• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前三轮疫苗接种情况:接种率下降。

The pattern from the first three rounds of vaccination: declining vaccination rates.

机构信息

Department of Health Management, College of Public Health, Zhengzhou University, Henan, China.

Henan Province Enginering, Research Center of Health Economy and Health Technology Assessment, Zhengzhou, Henan, China.

出版信息

Front Public Health. 2023 May 12;11:1124548. doi: 10.3389/fpubh.2023.1124548. eCollection 2023.

DOI:10.3389/fpubh.2023.1124548
PMID:37250076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10213674/
Abstract

INTRODUCTION

Vaccination rates for the COVID-19 vaccine have recently been stagnant worldwide. We aim to analyze the potential patterns of vaccination development from the first three doses to reveal the possible trends of the next round of vaccination and further explore the factors influencing vaccination in the selected populations.

METHODS

On July 2022, a stratified multistage random sampling method in the survey was conducted to select 6,781 people from 4 provinces China, who were above the age of 18 years. Participants were divided into two groups based on whether they had a chronic disease. The data were run through Cochran-Armitage trend test and multivariable regression analyses.

RESULTS

A total of 957 participants with chronic disease and 5,454 participants without chronic disease were included in this survey. Vaccination rates for the first, second and booster doses in chronic disease population were93.70% (95% CI: 92.19-95.27%), 91.12% (95%CI: 94.43-95.59%), and 83.18% (95%CI: 80.80-85.55%) respectively. By contrast, the first, second and booster vaccination rates for the general population were 98.02% (95% CI: 97.65-98.39%), 95.01% (95% CI: 94.43-95.59%) and 85.06% (95% CI: 84.11-86.00%) respectively. The widening gap in vaccination rates was observed as the number of vaccinations increases. Higher self-efficacy was a significant factor in promoting vaccination, which has been observed in all doses of vaccines. Higher education level, middle level physical activity and higher public prevention measures play a positive role in vaccination among the general population, while alcohol consumption acts as a significant positive factor in the chronic disease population ( < 0.05).

CONCLUSION

As the number of vaccinations increases, the trend of decreasing vaccination rate is becoming more pronounced. In future regular vaccinations, we may face low vaccination rates as the increasing number of infections and the fatigue associated with the prolonged outbreak hamper vaccination. Measures need to be found to counter this downward trend such as improving the self-efficacy of the population.

摘要

引言

最近,全球范围内 COVID-19 疫苗的接种率一直停滞不前。我们旨在分析从前三剂疫苗接种情况中发现疫苗接种发展的潜在模式,以揭示下一轮疫苗接种的可能趋势,并进一步探讨选定人群中影响疫苗接种的因素。

方法

2022 年 7 月,采用分层多阶段随机抽样方法在 4 个省份进行了调查,共选取了 6781 名年龄在 18 岁以上的人群。根据是否患有慢性病,将参与者分为两组。通过 Cochran-Armitage 趋势检验和多变量回归分析对数据进行分析。

结果

本研究共纳入了 957 名患有慢性病的参与者和 5454 名没有慢性病的参与者。慢性病人群的第一、第二和加强针接种率分别为 93.70%(95%CI:92.19-95.27%)、91.12%(95%CI:94.43-95.59%)和 83.18%(95%CI:80.80-85.55%);相比之下,普通人群的第一、第二和加强针接种率分别为 98.02%(95%CI:97.65-98.39%)、95.01%(95%CI:94.43-95.59%)和 85.06%(95%CI:84.11-86.00%)。随着接种次数的增加,接种率的差距不断扩大。较高的自我效能感是促进接种的一个重要因素,这在所有疫苗剂量中都得到了观察。较高的教育水平、中等水平的身体活动和较高的公众预防措施对普通人群的接种起到了积极的作用,而在慢性病人群中,饮酒则是一个显著的积极因素(<0.05)。

结论

随着接种次数的增加,接种率呈下降趋势,且越来越明显。在未来的常规疫苗接种中,由于感染人数的增加和持续爆发带来的疲劳,疫苗接种率可能会降低。需要找到应对这种下降趋势的措施,如提高人群的自我效能感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbf/10213674/460b3913d674/fpubh-11-1124548-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbf/10213674/8f9cd39ffc2b/fpubh-11-1124548-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbf/10213674/460b3913d674/fpubh-11-1124548-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbf/10213674/8f9cd39ffc2b/fpubh-11-1124548-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbf/10213674/460b3913d674/fpubh-11-1124548-g002.jpg

相似文献

1
The pattern from the first three rounds of vaccination: declining vaccination rates.前三轮疫苗接种情况:接种率下降。
Front Public Health. 2023 May 12;11:1124548. doi: 10.3389/fpubh.2023.1124548. eCollection 2023.
2
Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.基于健康信念模型(HBM)的中国老年人对 COVID-19 疫苗加强针的接受情况及其影响因素:一项全国性横断面研究。
Front Public Health. 2022 Dec 15;10:986916. doi: 10.3389/fpubh.2022.986916. eCollection 2022.
3
Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.在奥密克戎出现后,马萨诸塞州邮政编码区域内 COVID-19 疫苗和加强针接种的不平等:一项基于人群的横断面研究。
PLoS Med. 2023 Jan 31;20(1):e1004167. doi: 10.1371/journal.pmed.1004167. eCollection 2023 Jan.
4
Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.与美国成年人接受 COVID-19 疫苗意愿相关的因素。
JAMA Netw Open. 2020 Oct 1;3(10):e2025594. doi: 10.1001/jamanetworkopen.2020.25594.
5
Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.中国基层医疗卫生机构新冠疫情防控管理团队的疫苗接种率及其对新冠疫苗的态度:一项横断面在线调查。
BMJ Open. 2022 Apr 7;12(4):e056345. doi: 10.1136/bmjopen-2021-056345.
6
The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China.中国中部地区医护人员和目标人群对 COVID-19 异源加强免疫接种的接受情况:一项横断面研究。
Front Public Health. 2022 Aug 1;10:943876. doi: 10.3389/fpubh.2022.943876. eCollection 2022.
7
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.BNT162b2 和 CoronaVac 新冠疫苗对奥密克戎 BA.2 亚谱系引起的 SARS-CoV-2 无症状和有症状感染的有效性:一项前瞻性队列研究。
Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12.
8
COVID-19 Vaccination Coverage among 42,565 Adults Amid the Spread of Omicron Variant in Beijing, China.中国北京奥密克戎变异株传播期间42565名成年人的新冠疫苗接种覆盖率
Vaccines (Basel). 2023 Mar 27;11(4):739. doi: 10.3390/vaccines11040739.
9
Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China.中国儿童看护者对儿童接种 COVID-19 疫苗加强针的风险认知与接受度之间的关系。
Front Public Health. 2022 Mar 16;10:834572. doi: 10.3389/fpubh.2022.834572. eCollection 2022.
10
COVID-19 Booster Vaccination Among Individuals With Schizophrenia in Israel.以色列精神分裂症患者的 COVID-19 加强针接种。
JAMA Psychiatry. 2022 May 1;79(5):508-512. doi: 10.1001/jamapsychiatry.2022.0382.

引用本文的文献

1
Perception of COVID-19 vaccines in rheumatology patients.风湿病患者对新冠疫苗的认知
Medicine (Baltimore). 2025 Aug 1;104(31):e43618. doi: 10.1097/MD.0000000000043618.
2
COVID-19 Vaccination and Vaccine Hesitancy in the Gaza Strip from a Cross-Sectional Survey in 2023: Prevalence, Risk Factors, and Associations with Health System Interventions.2023年加沙地带横断面调查中的新冠疫苗接种与疫苗犹豫:患病率、风险因素及与卫生系统干预措施的关联
Vaccines (Basel). 2024 Sep 26;12(10):1098. doi: 10.3390/vaccines12101098.
3
Does the resumption of international tourism heighten COVID-19 transmission?

本文引用的文献

1
The Effect of Preventive Measures and Vaccination against SARS-CoV-2 on the Infection Risk, Treatment, and Hospitalization: A Cross-Sectional Study of Algeria.《预防措施和 SARS-CoV-2 疫苗接种对感染风险、治疗和住院的影响:阿尔及利亚的横断面研究》。
Viruses. 2022 Dec 12;14(12):2771. doi: 10.3390/v14122771.
2
Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus.Vero细胞衍生的新型冠状病毒灭活疫苗在老年高血压和糖尿病患者中的免疫原性和安全性评估
Vaccines (Basel). 2022 Jun 25;10(7):1020. doi: 10.3390/vaccines10071020.
3
The Importance of Behavioral and Native Factors on COVID-19 Infection and Severity: Insights from a Preliminary Cross-Sectional Study.
国际旅游的恢复是否会加剧 COVID-19 的传播?
PLoS One. 2024 Feb 7;19(2):e0295249. doi: 10.1371/journal.pone.0295249. eCollection 2024.
4
Non-Pharmaceutical Interventions against COVID-19 Causing a Lower Trend in Age of LHON Onset.非药物干预措施降低 COVID-19 导致 LHON 发病年龄的趋势。
Genes (Basel). 2023 Jun 12;14(6):1253. doi: 10.3390/genes14061253.
行为因素和固有因素对新型冠状病毒肺炎感染及严重程度的影响:一项初步横断面研究的见解
Healthcare (Basel). 2022 Jul 19;10(7):1341. doi: 10.3390/healthcare10071341.
4
The association between lifestyle and COVID-19 vaccine hesitancy in China: A large-scale cross-sectional survey.生活方式与中国 COVID-19 疫苗犹豫的关联:一项大规模横断面调查。
J Affect Disord. 2022 Sep 15;313:92-99. doi: 10.1016/j.jad.2022.06.038. Epub 2022 Jun 23.
5
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine.辉瑞-BioNTech 新冠疫苗第三剂效力下降。
Nat Commun. 2022 Jun 9;13(1):3203. doi: 10.1038/s41467-022-30884-6.
6
Changes of COVID-19 Knowledge, Attitudes, Practices and Vaccination Willingness Among Residents in Jinan, China.中国济南居民对 COVID-19 的知识、态度、行为和疫苗接种意愿的变化。
Front Public Health. 2022 May 20;10:917364. doi: 10.3389/fpubh.2022.917364. eCollection 2022.
7
Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis.中国人对 HIV/AIDS 疫苗犹豫不决的原因:结构方程建模分析。
JMIR Public Health Surveill. 2022 Jun 30;8(6):e33995. doi: 10.2196/33995.
8
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.Covid-19 疫苗对奥密克戎(B.1.1.529)变异株的有效性。
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
9
Applying an extended protection motivation theory to predict Covid-19 vaccination intentions and uptake in 50-64 year olds in the UK.运用扩展保护动机理论预测英国 50-64 岁人群对 COVID-19 疫苗接种的意愿和接种率。
Soc Sci Med. 2022 Apr;298:114819. doi: 10.1016/j.socscimed.2022.114819. Epub 2022 Feb 24.
10
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.疫苗预防严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染和 COVID-19 疾病有效性的持续时间:系统评价和荟萃回归的结果。
Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23.